1. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama á Nijholt AA, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029–34.
2. Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1):229–36.
3. Chartier-Kastler E, Le Normand L, Ruffion A, Dargent F, Braguet R, Saussine C, et al. Sacral neuromodulation with the InterStim System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): results of clinical effectiveness, quality of life, patient-reported outcomes and safety in a French multicenter observational study. Eur Urol Focus. 2020.
4. Koldewijn EL, Rosier PF, Meuleman EJ, Koster AM, Debruyne FM, van Kerrebroeck PE. Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol. 1994;152(6 Pt 1):2071–5.
5. Adelstein SA, Lee W, Gioia K, Moskowitz D, Stamnes K, Lucioni A, et al. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique. Neurourol Urodyn. 2019;38(6):1595–601.